Morphine Market Size & Share, by Application (Pain Management, Diarrhea Suppressant); Mode of Administration (Injection, Oral) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 3602
  • Published Date: Jul 14, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2023 - 2035

Morphine Market size is predicted to cross USD 45 billion by the end of 2035, growing at a CAGR of 8% during the forecast period i.e., 2023 – 2035. In the year 2022, the industry size of morphine was USD 25 billion. The growth of this market can be attributed to the back of high prevalence of chronic diseases and orthopedic health issues raising the demand for morphine in the pain management sector. As per the estimates, by 2050 around 130 million people are expected to suffer from osteoarthritis out of which 40 million will be physically disabled across the globe.

People's lifestyle changes causing pain and the increasing number of surgical procedures may also drive the expansion of this morphine market. As a result of increased pain post-surgery, morphine is a common drug prescribed to patients after surgery to ease surgical pain. 

Morphine Market
Get more information on this report: Request Free Sample PDF

Global Morphine Market: Key Insights

Base Year


Forecast Year

2023 – 2035



Base Year Market Size

~ USD 25 billion

Forecast Year Market Size

~USD 45 billion

Regional Synopsis

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Morphine Market: Growth Drivers and Challenges


Growth Drivers

  • Expansion of Geriatric Population –. Morphine is widely used as a pain management medication in severe pain. The mostly old population suffers from these kinds of diseases and demands morphine as a pain-relieving medicine.
  • Increasing Support by Government for Opioid Use - Now that governments are also legalizing the use of opioids, increased government support for morphine use in the medical sector, especially in emerging markets, is anticipated to provide lucrative growth opportunities in the predicted period.
  • High Demand in Pharmaceutical Sector - It is used in the pharmaceutical industry to develop new drugs due to its multiple properties such as appetite stimulation, inflammation relief, nausea relief, epileptic seizure control, and treatment of psychiatric disorders. According to the Congressional Budget Office, the new drugs approved for sale raised by 60 percent between 2010 and 2019 in the United States.
  • Escalating Presence of Musculoskeletal Disorder – The prevalence of musculoskeletal diseases is at a high rate across the globe which further is expected to raise the demand for its medication thus driving the morphine market growth in the estimated period. Approximately 1.71 billion people worldwide suffer from musculoskeletal disorders, as per the February 2021 report by WHO. 


  • Concern Regarding the Misuse of Morphine – Morphine is a type of drug that can become addictive if used for a long period of time or in high quantity. Few individuals might use morphine as the mode of addiction and it becomes very difficult to get over this addiction. Therefore, when it becomes addiction people start misusing this morphine medication and it becomes harmful to an individual’s health. This is estimated to pose a limitation on the morphine market expansion in the upcoming future.  
  • Production Challenges
  • Standards Put Forward by Government

Morphine Segmentation

Application (Pain Management, Diarrhea Suppressant)

In application segmentation, the pain management segment is predicted to dominate the morphine market with a share of 69 percent by the end of 2035. If the patient's pain cannot be managed with regular pain relievers, then the patient is prescribed morphine sustained-release tablets to relieve severe pain. Opioids play an important role in ensuring adequate analgesia in acute postoperative situations. The presence of ailments such as cancer, and other diseases has increased the demand for morphine in ​​pain management. In a study, it was reported that almost 20% of doctors prescribe opioids such as morphine to patients admitted to the emergency ward.

Mode of Administration (Injection, Oral)

In terms of mode of administration, the oral segment in the morphine market is expected to observe the highest CAGR during the time period between 2023 – 2035. The oral segment includes morphine in oral tablet and pharmaceutical form. The immediate effect of the oral tablets is within 30 to 60 minutes due to which it is mostly opted by the patients. Moreover, oral morphine provides short as well as long-term severe pain through the capsule and extended-release tablet. Also, it is considered one of the easiest ways that can be taken by the patients themselves.

Our in-depth analysis of the global morphine market includes the following segments:


  • Pain Management
  •  Diarrhea Suppressant

         Mode of Administration

  • Injection
  • Oral

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Morphine Industry – Regional Synopsis

North American Market Statistics

The morphine market in the North America region is projected to observe the largest market revenue with a share of 35 percent throughout 2023 - 2035. This can be attributed to the increasing patient pool of osteoporosis. According to the statistics of the Centers for Disease Control and Prevention, 4.2% of men and 18.8% of women over the age of 50 years suffered from osteoporosis of the femur neck or lumbar spine.  Moreover, a high share of the geriatric population in countries, such as the United States and Canada, is estimated to boost the regional market growth. In addition, a rise in research collaboration numbers is among the factors anticipated to boost market expansion. Due to its pro-healthcare legislation, the United States has the largest share in this area.

APAC Market Analysis

In Asia Pacific, the morphine sector is assumed to witness a substantial market extension of 28 percent by the end of 2035. The increasing investment in the healthcare sector and rising awareness about palliative care medication in the region are expected to drive market growth in the Asia Pacific region.  Some countries such as India, and China have well-developed healthcare infrastructure with proper pain management medications such as morphine use, but at the same time, few regions still working on implementing these chronic disease management solutions that include chronic pain management in the region. As per the India Brand Equity Foundation, the government of India is planning to launch a credit incentive program to boost the healthcare infrastructure accounting for USD 6.8 billion.

Research Nester
Morphine Market Size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Morphine Landscape

    • Verve Health Care Ltd.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis 
    • Mayne Pharma Group
    • Daiichi Sankyo Company Limited
    • Hikma Pharmaceuticals USA
    • AbbVie Inc.
    • Mylan N.V.
    • Sun Pharmaceutical Industries Ltd.
    • Alcaliber S.A.
    • Mallinckrodt Pharmaceuticals
    • AstraZeneca plc


In The News

  • Pfizer Inc. received U.S. FDA approval for tanezumab, a potential treatment for chronic pain due to moderate to severe osteoarthritis. 
  •  Mylan N.V. and Upjohn, a subdivision of Pfizer Inc. collectively established a new pharmaceutical company, Vitaris Inc.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 3602
  • Published Date: Jul 14, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The growing application of medical morphine as a pain killer is estimated to boost market growth.

The market is anticipated to attain a CAGR of ~8% over the forecast period, i.e., 2023 – 2035.

The major players in the market are Mayne Pharma Group, Daiichi Sankyo Company Limited, Hikma Pharmaceuticals USA, AbbVie Inc., Mylan N.V., Sun Pharmaceutical Industries Ltd., Alcaliber S.A., and others.

The market size of morphine is predicted to reach USD 45 Billion in 2035.

The poppy plants, Papaver somniferum are used to produce opium
Morphine Market Report Scope

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying